Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose thiotepa plus conventional chemotherapy for resectable relapsed osteosarcoma
2009-009899-12Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of thiotepa in osteosarcoma (OS) (2 arms), sponsored by Centre Léon Bérard. Primary endpoint: Overall survival at 24 months. Started Mar 2009; status: completed.
02
Drugs
thiotepa
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on 2009-009899-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009899-12.